Home›Trial›NCT07073014
🔬NCT07073014Phase 3ENROLLING BY INVITATION

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Study Summary

The purpose of this study is to evaluate the long-term safety and efficacy of daily doses of vosoritide in participants with HCH

Conditions
Hypochondroplasia
Interventions / Drugs
Vosoritide
View on ClinicalTrials.gov ↗
Sponsor
BMRN
BioMarin Pharmaceutical
Rare Disease
D36/100
Study Details
Enrollment140 participants
Primary Completion—
Lead SponsorBioMarin Pharmaceutical
Data Retrieved2026-04-11 02:55:23.531355+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.